Xie X - Search Results

1

Design and synthesis of aryloxypropanolamine as β₃-adrenergic receptor antagonist in cancer and lipolysis.

Jin J, Miao C, Wang Z, Zhang W, Zhang X, Xie X, Lu W. Jin J, et al. Among authors: xie x. Eur J Med Chem. 2018 Apr 25;150:757-770. doi: 10.1016/j.ejmech.2018.03.032. Epub 2018 Mar 17. Eur J Med Chem. 2018. PMID: 29574204

2

Philinopside E, a new sulfated saponin from sea cucumber, blocks the interaction between kinase insert domain-containing receptor (KDR) and alphavbeta3 integrin via binding to the extracellular domain of KDR.

Tian F, Zhu CH, Zhang XW, Xie X, Xin XL, Yi YH, Lin LP, Geng MY, Ding J. Tian F, et al. Among authors: xie x. Mol Pharmacol. 2007 Sep;72(3):545-52. doi: 10.1124/mol.107.036350. Epub 2007 Jun 12. Mol Pharmacol. 2007. PMID: 17565003

3

Synthesis and opioid receptor activity of indolopropellanes.

Li F, Gaob L, Yin C, Chen J, Liu J, Xie X, Zhang A. Li F, et al. Among authors: xie x. Bioorg Med Chem Lett. 2009 Aug 15;19(16):4603-6. doi: 10.1016/j.bmcl.2009.06.093. Epub 2009 Jun 30. Bioorg Med Chem Lett. 2009. PMID: 19595591

4

Discovery of benzhydrylpiperazine derivatives as CB1 receptor inverse agonists via privileged structure-based approach.

Meng T, Wang J, Peng H, Fang G, Li M, Xiong B, Xie X, Zhang Y, Wang X, Shen J. Meng T, et al. Among authors: xie x. Eur J Med Chem. 2010 Mar;45(3):1133-9. doi: 10.1016/j.ejmech.2009.12.018. Epub 2009 Dec 16. Eur J Med Chem. 2010. PMID: 20047779

5

Structural optimization and biological evaluation of substituted bisphenol A derivatives as beta-amyloid peptide aggregation inhibitors.

Zhou Y, Jiang C, Zhang Y, Liang Z, Liu W, Wang L, Luo C, Zhong T, Sun Y, Zhao L, Xie X, Jiang H, Zhou N, Liu D, Liu H. Zhou Y, et al. Among authors: xie x. J Med Chem. 2010 Aug 12;53(15):5449-66. doi: 10.1021/jm1000584. J Med Chem. 2010. PMID: 20684593

6

Asymmetric synthesis and biological evaluation of N-cyclohexyl-4-[1-(2,4-dichlorophenyl)-1-(p-tolyl)methyl]piperazine-1-carboxamide as hCB1 receptor antagonists.

Gao L, Li M, Meng T, Peng H, Xie X, Zhang Y, Jin Y, Wang X, Zou L, Shen J. Gao L, et al. Among authors: xie x. Eur J Med Chem. 2011 Nov;46(11):5310-6. doi: 10.1016/j.ejmech.2011.08.030. Epub 2011 Sep 1. Eur J Med Chem. 2011. PMID: 21937154

7

Gold(I)-catalyzed cascade approach for the synthesis of tryptamine-based polycyclic privileged scaffolds as α1-adrenergic receptor antagonists.

Li Z, Li J, Yang N, Chen Y, Zhou Y, Ji X, Zhang L, Wang J, Xie X, Liu H. Li Z, et al. Among authors: xie x. J Org Chem. 2013 Nov 1;78(21):10802-11. doi: 10.1021/jo4017887. Epub 2013 Oct 23. J Org Chem. 2013. PMID: 24099012

8

Design, synthesis, and biological evaluation of novel piperidine-4-carboxamide derivatives as potent CCR5 inhibitors.

Hu S, Gu Q, Wang Z, Weng Z, Cai Y, Dong X, Hu Y, Liu T, Xie X. Hu S, et al. Among authors: xie x. Eur J Med Chem. 2014 Jan;71:259-66. doi: 10.1016/j.ejmech.2013.11.013. Epub 2013 Nov 19. Eur J Med Chem. 2014. PMID: 24316669

9

Design, synthesis, biological evaluation, and comparative docking study of 1,2,4-triazolones as CB1 receptor selective antagonists.

Han S, Zhang FF, Xie X, Chen JZ. Han S, et al. Among authors: xie x. Eur J Med Chem. 2014 Mar 3;74:73-84. doi: 10.1016/j.ejmech.2013.12.018. Epub 2013 Dec 31. Eur J Med Chem. 2014. PMID: 24445310

10

Identification of a novel small-molecule agonist for human G protein-coupled receptor 3.

Ye C, Zhang Z, Wang Z, Hua Q, Zhang R, Xie X. Ye C, et al. Among authors: xie x. J Pharmacol Exp Ther. 2014 Jun;349(3):437-43. doi: 10.1124/jpet.114.213082. Epub 2014 Mar 14. J Pharmacol Exp Ther. 2014. PMID: 24633425

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17,603 results

Search Page

Filters